Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard West

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Neoplasia (New York, N.Y.)|June 22, 2023
Challenges in synergizing radiotherapy with immunotherapy to unlock the abscopal effect in metastatic NSCLC: A systematic reviewJason Liu, Howard West, Heather M McGee, et al.
Future Oncology (London, England)|May 23, 2023
Clinical and economic impact of recurrence in early-stage non-small-cell lung cancer following complete resectionHoward West, Xiaohan Hu, Diana Chirovsky, et al.
JCO Oncology Practice|January 5, 2022
Tragic Triad of Tobacco Dependence, Cancer, and COVID-19 Pandemic: An Urgent Call for Attention by Health Care Systems and ProfessionalsCary A Presant, Jonjon Macalintal, Kimlin Tam Ashing, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 30, 2009
Impact of the ASCO 2007 presentation of HOG Lun 01-24/USO-023 on the prescribing plans of American medical oncologists for patients with stage IIIB non-small cell lung cancerMark R Green, Howard West, Mark A Socinski, et al.
Lung Cancer Management|December 15, 2020
Humanistic burden of living with anaplastic lymphoma kinase-positive non-small-cell lung cancer: findings from the ALKConnect patient insight network and research platformHuamao M Lin, Xiaoyun Pan, Alyssa Biller, et al.
Journal of Managed Care & Specialty Pharmacy|July 5, 2023
Evaluation of disease-free survival as a predictor of overall survival and assessment of real-world burden of disease recurrence in resected early-stage non-small cell lung cancerHoward West, Xiaohan Hu, Su Zhang, et al.
Clinical Lung Cancer|January 14, 2023
Treatment Patterns and Outcomes in Resected Early-stage Non-small Cell Lung Cancer: An Analysis of the SEER-Medicare DataHoward West, Xiaohan Hu, Su Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2009
Phase II trial of irinotecan and carboplatin for extensive or relapsed small-cell lung cancerGigi Chen, Minh Huynh, Lou Fehrenbacher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2014
Molecular testing for selection of patients with lung cancer for epidermal growth factor receptor and anaplastic lymphoma kinase tyrosine kinase inhibitors: American Society of Clinical Oncology endorsement of the College of American Pathologists/International Association for the study of lung cancer/association for molecular pathology guidelineNatasha B Leighl, Natasha Rekhtman, William A Biermann, et al.
JCO Precision Oncology|September 1, 2023
Targeted Therapies in Early-Stage Resectable Non-Small-Cell Lung Cancer: New Kids on the BlockJason Liu, Arya Amini, Ameish Govindarajan, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Neoplasia (New York, N.Y.)|June 22, 2023
Challenges in synergizing radiotherapy with immunotherapy to unlock the abscopal effect in metastatic NSCLC: A systematic reviewJason Liu, Howard West, Heather M McGee, et al.
Future Oncology (London, England)|May 23, 2023
Clinical and economic impact of recurrence in early-stage non-small-cell lung cancer following complete resectionHoward West, Xiaohan Hu, Diana Chirovsky, et al.
JCO Oncology Practice|January 5, 2022
Tragic Triad of Tobacco Dependence, Cancer, and COVID-19 Pandemic: An Urgent Call for Attention by Health Care Systems and ProfessionalsCary A Presant, Jonjon Macalintal, Kimlin Tam Ashing, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 30, 2009
Impact of the ASCO 2007 presentation of HOG Lun 01-24/USO-023 on the prescribing plans of American medical oncologists for patients with stage IIIB non-small cell lung cancerMark R Green, Howard West, Mark A Socinski, et al.
Lung Cancer Management|December 15, 2020
Humanistic burden of living with anaplastic lymphoma kinase-positive non-small-cell lung cancer: findings from the ALKConnect patient insight network and research platformHuamao M Lin, Xiaoyun Pan, Alyssa Biller, et al.
Journal of Managed Care & Specialty Pharmacy|July 5, 2023
Evaluation of disease-free survival as a predictor of overall survival and assessment of real-world burden of disease recurrence in resected early-stage non-small cell lung cancerHoward West, Xiaohan Hu, Su Zhang, et al.
Clinical Lung Cancer|January 14, 2023
Treatment Patterns and Outcomes in Resected Early-stage Non-small Cell Lung Cancer: An Analysis of the SEER-Medicare DataHoward West, Xiaohan Hu, Su Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2009
Phase II trial of irinotecan and carboplatin for extensive or relapsed small-cell lung cancerGigi Chen, Minh Huynh, Lou Fehrenbacher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2014
Molecular testing for selection of patients with lung cancer for epidermal growth factor receptor and anaplastic lymphoma kinase tyrosine kinase inhibitors: American Society of Clinical Oncology endorsement of the College of American Pathologists/International Association for the study of lung cancer/association for molecular pathology guidelineNatasha B Leighl, Natasha Rekhtman, William A Biermann, et al.
JCO Precision Oncology|September 1, 2023
Targeted Therapies in Early-Stage Resectable Non-Small-Cell Lung Cancer: New Kids on the BlockJason Liu, Arya Amini, Ameish Govindarajan, et al.
Pageof 5